Previously, there were no clear regulatory requirements for such types of medical devices, but Article 117 of the EU MDR has provided an amendment outlining specific requirements for drug device combination medical products.
This whitepaper offers advice to prepare drug device combination product manufacturers for the new regulations, including:
- Seeking Notified Body opinion
- Products covered
- Marketing Authorization applications
- General Safety and Performance Requirements (GSPRs)
To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content. Have any questions or interested in sponsoring future content? Email email@example.com.